Joel R. Chamberlain

2.3k total citations
23 papers, 1.6k citations indexed

About

Joel R. Chamberlain is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Joel R. Chamberlain has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Genetics and 4 papers in Genetics. Recurrent topics in Joel R. Chamberlain's work include Muscle Physiology and Disorders (10 papers), Virus-based gene therapy research (8 papers) and RNA Research and Splicing (6 papers). Joel R. Chamberlain is often cited by papers focused on Muscle Physiology and Disorders (10 papers), Virus-based gene therapy research (8 papers) and RNA Research and Splicing (6 papers). Joel R. Chamberlain collaborates with scholars based in United States, Hungary and Cameroon. Joel R. Chamberlain's co-authors include Jeffrey S. Chamberlain, David R. Engelke, Roli K. Hirata, David W. Russell, William S. Lane, Yoon Lee, Guy L. Odom, John K. Hall, Rong Dong and Michael Phelps and has published in prestigious journals such as Science, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Joel R. Chamberlain

23 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel R. Chamberlain United States 15 1.4k 562 187 152 97 23 1.6k
Michel van Geel Netherlands 26 1.5k 1.1× 616 1.1× 105 0.6× 80 0.5× 89 0.9× 93 2.1k
Caroline Rooryck France 25 1.0k 0.8× 668 1.2× 156 0.8× 277 1.8× 164 1.7× 75 1.9k
Caroline Le Guiner France 20 1.3k 1.0× 657 1.2× 83 0.4× 158 1.0× 65 0.7× 47 1.6k
Fedik Rahimov United States 19 1.1k 0.8× 627 1.1× 278 1.5× 153 1.0× 211 2.2× 24 1.7k
Kyeyoon Park United States 19 1.4k 1.0× 292 0.5× 126 0.7× 368 2.4× 128 1.3× 25 1.8k
Yan Geng China 11 1.1k 0.8× 215 0.4× 136 0.7× 179 1.2× 139 1.4× 28 1.3k
Laetitia van Wittenberghe France 15 1.2k 0.9× 583 1.0× 272 1.5× 113 0.7× 268 2.8× 26 1.6k
Christel Rivière France 11 520 0.4× 454 0.8× 182 1.0× 101 0.7× 52 0.5× 13 967
Ellen van Beusekom Netherlands 10 1.1k 0.8× 273 0.5× 116 0.6× 93 0.6× 134 1.4× 15 1.4k
Graham McClorey United Kingdom 24 1.7k 1.3× 353 0.6× 243 1.3× 204 1.3× 85 0.9× 41 1.8k

Countries citing papers authored by Joel R. Chamberlain

Since Specialization
Citations

This map shows the geographic impact of Joel R. Chamberlain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel R. Chamberlain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel R. Chamberlain more than expected).

Fields of papers citing papers by Joel R. Chamberlain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel R. Chamberlain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel R. Chamberlain. The network helps show where Joel R. Chamberlain may publish in the future.

Co-authorship network of co-authors of Joel R. Chamberlain

This figure shows the co-authorship network connecting the top 25 collaborators of Joel R. Chamberlain. A scholar is included among the top collaborators of Joel R. Chamberlain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel R. Chamberlain. Joel R. Chamberlain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gudsnuk, Kathryn, et al.. (2019). Endogenous MicroRNA Competition as a Mechanism of shRNA-Induced Cardiotoxicity. Molecular Therapy — Nucleic Acids. 19. 572–580. 4 indexed citations
2.
Chamberlain, Joel R., et al.. (2017). Progress toward Gene Therapy for Duchenne Muscular Dystrophy. Molecular Therapy. 25(5). 1125–1131. 151 indexed citations
3.
Bengtsson, Niclas E., John K. Hall, Guy L. Odom, et al.. (2017). Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nature Communications. 8(1). 14454–14454. 305 indexed citations
4.
Stępniak-Konieczna, Ewa, et al.. (2015). Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy. Human Molecular Genetics. 24(17). 4971–4983. 42 indexed citations
5.
Arnett, Andrea, Patryk Konieczny, Julian N. Ramos, et al.. (2014). Adeno-associated viral vectors do not efficiently target muscle satellite cells. Molecular Therapy — Methods & Clinical Development. 1. 14038–14038. 81 indexed citations
6.
Wei, Jessica & Joel R. Chamberlain. (2014). Systemic RNAi Delivery to the Muscles of ROSA26 Mice Reduces lacZ Expression. PLoS ONE. 9(8). e102053–e102053. 2 indexed citations
7.
Ng, Rainer, Glen B. Banks, John K. Hall, et al.. (2011). Animal Models of Muscular Dystrophy. Progress in molecular biology and translational science. 105. 83–111. 36 indexed citations
8.
Bortolanza, Sergia, Alessandro Nonis, Francesca Sanvito, et al.. (2011). AAV6-mediated Systemic shRNA Delivery Reverses Disease in a Mouse Model of Facioscapulohumeral Muscular Dystrophy. Molecular Therapy. 19(11). 2055–2064. 37 indexed citations
9.
Carter, Gregory T., Michael D. Weiss, Joel R. Chamberlain, et al.. (2010). Aging with Muscular Dystrophy: Pathophysiology and Clinical Management. Physical Medicine and Rehabilitation Clinics of North America. 21(2). 429–450. 5 indexed citations
10.
Chamberlain, Joel R. & Jeffrey S. Chamberlain. (2010). Muscling in: Gene therapies for muscular dystrophy target RNA. Nature Medicine. 16(2). 170–171. 7 indexed citations
11.
Arnett, Andrea, Joel R. Chamberlain, & Jeffrey S. Chamberlain. (2009). Therapy for neuromuscular disorders. Current Opinion in Genetics & Development. 19(3). 290–297. 19 indexed citations
12.
Banks, Glen B., Ariana C. Combs, Joel R. Chamberlain, & Jeffrey S. Chamberlain. (2008). Molecular and cellular adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated dystrophin. Human Molecular Genetics. 17(24). 3975–3986. 36 indexed citations
13.
Chamberlain, Joel R., David R. Deyle, Ulrike Schwarze, et al.. (2007). Gene Targeting of Mutant COL1A2 Alleles in Mesenchymal Stem Cells From Individuals With Osteogenesis Imperfecta. Molecular Therapy. 16(1). 187–193. 65 indexed citations
14.
Chamberlain, Joel R., et al.. (2003). Classroom note: M-bonacci numbers and their finite sums. International Journal of Mathematical Education in Science and Technology. 34(6). 935–940. 3 indexed citations
15.
Hirata, Roli K., Joel R. Chamberlain, Rong Dong, & David W. Russell. (2002). Targeted transgene insertion into human chromosomes by adeno-associated virus vectors. Nature Biotechnology. 20(7). 735–738. 139 indexed citations
16.
Chamberlain, Joel R., et al.. (2000). Recombinant adenovirus serotype switching for analysis of efficiency and route of intestinalcell entry. Gastroenterology. 118(4). A99–A99. 1 indexed citations
17.
Chamberlain, Joel R., Yoon Lee, William S. Lane, & David R. Engelke. (1998). Purification and characterization of the nuclear RNase P holoenzyme complex reveals extensive subunit overlap with RNase MRP. Genes & Development. 12(11). 1678–1690. 202 indexed citations
18.
Fan, Hao, John Goodier, Joel R. Chamberlain, David R. Engelke, & Richard J Maraia. (1998). 5′ Processing of tRNA Precursors Can Be Modulated by the Human La Antigen Phosphoprotein. Molecular and Cellular Biology. 18(6). 3201–3211. 100 indexed citations
19.
Chamberlain, Joel R.. (1996). An RNase P RNA subunit mutation affects ribosomal RNA processing. Nucleic Acids Research. 24(16). 3158–3166. 58 indexed citations
20.
Chamberlain, Joel R., et al.. (1996). Eukaryotic Nuclear RNase P: Structures and Functions. Progress in nucleic acid research and molecular biology. 55. 87–119. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel van Geel Breakdown of academic impact, for papers by Caroline Rooryck Breakdown of academic impact, for papers by Caroline Le Guiner Breakdown of academic impact, for papers by Fedik Rahimov Breakdown of academic impact, for papers by Kyeyoon Park Breakdown of academic impact, for papers by Yan Geng Breakdown of academic impact, for papers by Laetitia van Wittenberghe Breakdown of academic impact, for papers by Christel Rivière Breakdown of academic impact, for papers by Ellen van Beusekom Breakdown of academic impact, for papers by Graham McClorey
Rankless by CCL
2026